Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  T.WELL.DB | WHTCF

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.


TSX:WELL - Post by User

Post by ahsh1kahon Aug 14, 2024 10:54am
618 Views
Post# 36178480

Q2 Positives & Negatives summary

Q2 Positives & Negatives summary
Positive
 
- Record quarterly revenue of $243.1 million, a 42% increase YoY.
- Adjusted EBITDA increased by 11% to $30.9 million.
- 1.4 million patient visits, a 38% increase YoY.
- U.S. digital revenues rose by 40% to $56.3 million.
- Raised annual revenue forecast to $970 million to $990 million.
- Generated $35.2 million in operating cash flow.
- Paid down $14 million in debt.
 
Negative
 
- Adjusted Gross Margin declined to 44.2% from 53.1%
- Adjusted Net Income decreased to $12.3 million from $14.4 million.
- Free cash flow attributable to shareholders decreased to $8.7 million from $9.4 million.

 (Per the release, the declines is attributed to the acquisition of businesses in the past year that had lower gross margin percentage)
<< Previous
Bullboard Posts
Next >>